These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 32142713)
1. Moving on from the failed HIV vaccine clinical trial. Adepoju P Lancet HIV; 2020 Mar; 7(3):e161. PubMed ID: 32142713 [No Abstract] [Full Text] [Related]
2. South African AIDS Vaccine Initiative launches phase I trial. Kresge KJ IAVI Rep; 2009; 13(4):19. PubMed ID: 20225578 [No Abstract] [Full Text] [Related]
3. Why we don't need a relative risk standard for adolescent HIV vaccine trials in South Africa. Slack CM Am J Bioeth; 2011 Jun; 11(6):21-2. PubMed ID: 21678209 [No Abstract] [Full Text] [Related]
4. (Un)risky business: adolescents and HIV prevention trials. Philpott S Am J Bioeth; 2011 Jun; 11(6):17-9. PubMed ID: 21678207 [No Abstract] [Full Text] [Related]
5. The HVTN 503/Phambili study: efficacy is always the issue. Dhesi Z; Stebbing J Lancet Infect Dis; 2011 Jul; 11(7):490-1. PubMed ID: 21570356 [No Abstract] [Full Text] [Related]
6. The potential impact of a moderately effective HIV vaccine with rapidly waning protection in South Africa and Thailand. Andersson KM; Stover J Vaccine; 2011 Aug; 29(36):6092-9. PubMed ID: 21703322 [TBL] [Abstract][Full Text] [Related]
8. HIV: a tale of two centres. Cherry M Nature; 2007 May; 447(7140):26-7. PubMed ID: 17476240 [No Abstract] [Full Text] [Related]
9. Combo of two HIV vaccines fails its big test. Cohen J Science; 2020 Feb; 367(6478):611-612. PubMed ID: 32029605 [No Abstract] [Full Text] [Related]
10. First candidate enrolled in new HIV vaccine trial. Expert Rev Vaccines; 2003 Dec; 2(6):732-3. PubMed ID: 15278999 [No Abstract] [Full Text] [Related]
11. Controversial HIV vaccine strategy gets a second chance. Cohen J Science; 2016 Nov; 354(6312):535. PubMed ID: 27811245 [No Abstract] [Full Text] [Related]
12. Here's my arm. My personal experience participating in an HIV-vaccine trial. Abitol G Body Posit; 2004; 17(4):22-3. PubMed ID: 15929211 [No Abstract] [Full Text] [Related]
13. 'Mosaic' HIV vaccine to be tested in thousands of people across the world. Mega ER Nature; 2019 Aug; 572(7768):165-166. PubMed ID: 31388154 [No Abstract] [Full Text] [Related]
14. Scientific justification for the participation of children and adolescents in HIV-1 vaccine trials in South Africa. Jaspan HB; Gray GE; Robinson AK; Coovadia HM; Bekker LG S Afr Med J; 2005 Sep; 95(9):685-7. PubMed ID: 16327928 [No Abstract] [Full Text] [Related]
15. AIDS vaccine test to be expanded based on upbeat results. AIDS Read; 2005 Nov; 15(11):561, 573. PubMed ID: 16329176 [No Abstract] [Full Text] [Related]
16. A relative standard for minimal risk is unnecessary and potentially harmful to children: lessons from the Phambili trial. Nelson RM Am J Bioeth; 2011 Jun; 11(6):14-6. PubMed ID: 21678206 [No Abstract] [Full Text] [Related]
17. The RV144 Thai HIV vaccine trial. Plotkin SA Hum Vaccin; 2010 Feb; 6(2):159. PubMed ID: 20431337 [No Abstract] [Full Text] [Related]
18. The HIV vaccine pipeline, from preclinical to phase III. Schultz AM; Bradac JA AIDS; 2001; 15 Suppl 5():S147-58. PubMed ID: 11816163 [No Abstract] [Full Text] [Related]
19. The HVTN503/Phambili HIV vaccine trial: a comparison of younger and older participants. Volk JE; Hessol NA; Gray GE; Kublin JG; Churchyard GJ; Mlisana K; Nchabeleng M; Buchbinder SP; Bekker LG Int J STD AIDS; 2014 Apr; 25(5):332-40. PubMed ID: 24104693 [TBL] [Abstract][Full Text] [Related]
20. In search of a human immunodeficiency virus vaccine. Bartholomew CF West Indian Med J; 2000 Sep; 49(3):187-9. PubMed ID: 11076204 [No Abstract] [Full Text] [Related] [Next] [New Search]